Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 7 | 143264093 | missense variant | G/A | snv | 1.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2007 | 2010 | |||||||
|
0.925 | 0.080 | 7 | 143264093 | missense variant | G/A | snv | 1.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2007 | 2010 | |||||||
|
0.851 | 0.200 | 7 | 143265021 | missense variant | G/A | snv | 7.6E-05 | 2.1E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2007 | 2010 | ||||||
|
0.851 | 0.200 | 7 | 143265021 | missense variant | G/A | snv | 7.6E-05 | 2.1E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2007 | 2010 | ||||||
|
7 | 143268092 | missense variant | C/A;T | snv | 8.0E-06; 8.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
7 | 143268092 | missense variant | C/A;T | snv | 8.0E-06; 8.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
1.000 | 0.080 | 7 | 143267656 | missense variant | G/A | snv | 8.0E-06 | 1.4E-05 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.925 | 0.040 | 7 | 143264131 | missense variant | C/A;T | snv | 4.0E-06 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 7 | 143264131 | missense variant | C/A;T | snv | 4.0E-06 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
7 | 143262206 | intron variant | G/A;T | snv | 1.8E-02 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||||
|
0.851 | 0.200 | 7 | 143265021 | missense variant | G/A | snv | 7.6E-05 | 2.1E-05 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.851 | 0.200 | 7 | 143265021 | missense variant | G/A | snv | 7.6E-05 | 2.1E-05 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
1.000 | 0.080 | 7 | 143268091 | missense variant | G/A | snv | 2.0E-05 | 1.4E-05 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.882 | 0.240 | 7 | 143263541 | frameshift variant | TCTTCTATGACGTGCTGTC/- | delins | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2003 | 2003 | |||||||
|
0.882 | 0.240 | 7 | 143263541 | frameshift variant | TCTTCTATGACGTGCTGTC/- | delins | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.240 | 7 | 143263541 | frameshift variant | TCTTCTATGACGTGCTGTC/- | delins | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.851 | 0.160 | 7 | 143267618 | missense variant | C/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.160 | 7 | 143267618 | missense variant | C/A | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | ||||||||
|
0.851 | 0.160 | 7 | 143267618 | missense variant | C/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.160 | 7 | 143267618 | missense variant | C/A | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | ||||||||
|
0.851 | 0.160 | 7 | 143267618 | missense variant | C/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.160 | 7 | 143267618 | missense variant | C/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 7 | 143265168 | missense variant | G/A | snv | 4.1E-06 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2016 | 2016 |